Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal. But weight loss doesn't discriminate ...

Recent Study Testing International Formulation Shows Significant Increase in GLP-1 HormoneSALT LAKE CITY, Feb. 04, 2025 ...

Divi's Laboratories share price surged 5.36 per cent at Rs 6,205 per share on the BSE in the intraday trade of Tuesday. This ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Patients using GLP-1 drugs can experience rapid and substantial ... In the time between growth hormone’s arrival and IGF1 synthesis, there is a complex web of proteins that determine how much ...

Divi’s Laboratories share price gained 5% as the pharma company reported a 64.5% YoY profit increase in Q3 FY25, driven by ...